BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26141914)

  • 1. Acceptable and Preferred Cervical Cancer Screening Intervals Among U.S. Women.
    Cooper CP; Saraiya M; Sawaya GF
    Am J Prev Med; 2015 Dec; 49(6):e99-107. PubMed ID: 26141914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical Cancer Screening Intervals Preferred by U.S. Women.
    Cooper CP; Saraiya M
    Am J Prev Med; 2018 Sep; 55(3):389-394. PubMed ID: 30033024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary HPV testing: U.S. women's awareness and acceptance of an emerging screening modality.
    Saraiya M; Kwan A; Cooper CP
    Prev Med; 2018 Mar; 108():111-114. PubMed ID: 29277414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The recommended interval for cervical cancer screening: Victorian women's attitudes to an extended interval.
    Scalzo K; Mullins R
    Aust N Z J Public Health; 2015 Apr; 39(2):153-6. PubMed ID: 25716065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening among women ≥70 years of age in the United States-A referral problem or patient choice.
    Guo F; Hirth JM; Berenson AB
    Prev Med; 2015 Dec; 81():427-32. PubMed ID: 26500084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for cervical cancer: will women accept less?
    Sirovich BE; Woloshin S; Schwartz LM
    Am J Med; 2005 Feb; 118(2):151-8. PubMed ID: 15694900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician recommendation for papanicolaou testing among U.S. women, 2000.
    Coughlin SS; Breslau ES; Thompson T; Benard VB
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding women's hesitancy to undergo less frequent cervical cancer screening.
    Gerend MA; Shepherd MA; Kaltz EA; Davis WJ; Shepherd JE
    Prev Med; 2017 Feb; 95():96-102. PubMed ID: 27932055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population-based study of US women's preferred versus usual sources of reproductive health care.
    Hall KS; Patton EW; Crissman HP; Zochowski MK; Dalton VK
    Am J Obstet Gynecol; 2015 Sep; 213(3):352.e1-14. PubMed ID: 25935780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
    Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
    J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.
    Perkins RB; Anderson BL; Gorin SS; Schulkin JA
    Am J Prev Med; 2013 Aug; 45(2):175-81. PubMed ID: 23867024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening among women aged 18-30 years - United States, 2000-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jan; 61(51-52):1038-42. PubMed ID: 23282861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the role of violence in incarcerated women's cervical cancer screening and history.
    Ramaswamy M; Kelly PJ; Koblitz A; Kimminau KS; Engelman KK
    Women Health; 2011 Jul; 51(5):423-41. PubMed ID: 21797677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border.
    Nuño T; Castle PE; Harris R; Estrada A; García F;
    J Womens Health (Larchmt); 2011 May; 20(5):685-93. PubMed ID: 21428792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Cardiovascular Disease on Compliance with Cervical and Breast Cancer Screening Recommendations Among Adult Women.
    Guo F; Hirth JM; Berenson AB
    J Womens Health (Larchmt); 2015 Aug; 24(8):641-7. PubMed ID: 26263281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening in the United States, 1993-2010: characteristics of women who are never screened.
    Chen HY; Kessler CL; Mori N; Chauhan SP
    J Womens Health (Larchmt); 2012 Nov; 21(11):1132-8. PubMed ID: 22873781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of Cervical Cancer Screening Adherence Among Women in the U.S.: Findings from HINTS 2013-2014.
    Luque JS; Tarasenko YN; Chen C
    J Prim Prev; 2018 Aug; 39(4):329-344. PubMed ID: 29876723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recency of Pap testing and future testing plans among women aged 18-64: analysis of the 2007 Health Information National Trends Survey.
    Ashok M; Berkowitz Z; Hawkins NA; Tangka F; Saraiya M
    J Womens Health (Larchmt); 2012 Jul; 21(7):705-12. PubMed ID: 22480224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Cervical Cancer Screening in Title X-Funded Health Centers - United States, 2005-2015.
    Fowler CI; Saraiya M; Moskosky SB; Miller JW; Gable J; Mautone-Smith N
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(37):981-985. PubMed ID: 28934183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.